Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.5677 | 0.5637 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0658 | 1 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0036 | 0.1777 | 0.1701 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0024 | 0.0658 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0049 | 0.3083 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0036 | 0.1777 | 0.1198 |
Schistosoma mansoni | hypothetical protein | 0.0077 | 0.5677 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0024 | 0.0725 | 0.0276 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0024 | 0.0725 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0091 | 0.139 |
Mycobacterium ulcerans | hypothetical protein | 0.0024 | 0.0658 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0658 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0024 | 0.0658 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0077 | 0.5677 | 0.5372 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0658 | 0.0572 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0049 | 0.3083 | 0.5 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0658 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0049 | 0.3083 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0112 | 0.9038 | 0.9029 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0049 | 0.3083 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0725 | 0.0639 |
Onchocerca volvulus | Huntingtin homolog | 0.0122 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0112 | 0.9038 | 0.9029 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0024 | 0.0658 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0024 | 0.0725 | 1 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0049 | 0.3083 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0122 | 1 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.0049 | 0.3083 | 0.2596 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0049 | 0.3083 | 1 |
Onchocerca volvulus | Huntingtin homolog | 0.0122 | 1 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0091 | 0.5 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0024 | 0.0658 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0049 | 0.3083 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0024 | 0.0658 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0112 | 0.9038 | 0.897 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0658 | 0.0572 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.1777 | 0.1701 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0658 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0049 | 0.3083 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0049 | 0.3083 | 0.3019 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0049 | 0.3083 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0049 | 0.3083 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0049 | 0.3083 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0112 | 0.9038 | 0.897 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0024 | 0.0658 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0658 | 0.0572 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0024 | 0.0725 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0049 | 0.3083 | 0.5 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0725 | 0.0072 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0049 | 0.3083 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0024 | 0.0658 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0049 | 0.3083 | 1 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0049 | 0.3083 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0024 | 0.0658 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0049 | 0.3083 | 0.3349 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0049 | 0.3083 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0049 | 0.3083 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0036 | 0.1777 | 0.1198 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0024 | 0.0658 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0049 | 0.3083 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0024 | 0.0658 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 16.5113 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 | ||
Saccharomyces cerevisiae | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.